(Q40145018)

17 September 2017

1 reference

title

Prostacyclin--physiology and clinical uses (English)

1 reference

17 September 2017

Prostacyclin—Physiology and clinical uses (English)

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

2 October 2023

author name string

E. A. Higgs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6337922

2 October 2023

S. Moncada

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6337922

2 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6337922

2 October 2023

publication date

1 January 1983

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:030636238390054X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

https://api.elsevier.com/content/article/PII:030636238390054X?httpAccept=text/plain

2 October 2023

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

2 October 2023

1 reference

17 September 2017

volume

14

1 reference

17 September 2017

issue

1

1 reference

17 September 2017

page(s)

7-11

1 reference

Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease

17 September 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence

2 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

The effect of aspirin inhibition of PGI2 production on platelet adherence to normal and damaged rabbit aortae

2 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Prostacyclin production by arterialized autogenous venous grafts in dogs

2 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Recovery of prostacyclin production by de-endothelialized rabbit aorta. Critical role of neointimal smooth muscle cells

2 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

A double blind placebo controlled crossover study of prostacyclin in man

2 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Intravenous prostacyclin in thrombotic thrombocytopenic purpura

2 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries

2 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

The chemical structure of prostaglandin X (prostacyclin)

2 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Stimulation of calcium uptake in platelet membrane vesicles by adenosine 3′,5′-cyclic monophosphate and protein kinase

2 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Cyclic adenosine 3′,5′-monophosphate and prostacyclin inhibit membrane phospholipase activity in platelets

2 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets

2 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions

2 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Eighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclin

2 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Endothelial cell adenylate cyclase: activation by catecholamines and prostaglandin I2+

2 October 2023

22

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men

2 October 2023

24

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension

2 October 2023

27

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent

2 October 2023

28

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

Prostacyclin in central retinal vein occlusion

2 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0306-3623(83)90054-X

2 October 2023

Identifiers

1 reference

17 September 2017

1 reference